Metabolism of the Endocannabinoids Anandamide and 2-Arachidonoyl Glycerol, A Review, with Emphasis on the Pharmacology of Fatty Acid Amide Hydrolase, A Possible Target for the Treatment of Neurodegenerative Diseases and Pain

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|4|3|161-174

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.4, Iss.3, 2004-09, pp. : 161-174

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fatty acid amide hydrolase as a potential therapeutic target for the treatment of pain and CNS disorders

By Ahn Kay   Johnson Douglas S   Cravatt Benjamin F  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 7, 2009-07 ,pp. : 763-784

Informa Healthcare

Access to resources Recommend Favorite

An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity

By Ben-Shabat S.   Fride E.   Sheskin T.   Tamiri T.   Rhee M.-H.   Vogel Z.   Bisogno T.   De Petrocellis L.   Di Marzo V.   Mechoulam R.  

European Journal of Pharmacology, Vol. 353, Iss. 1, 1998-07 ,pp. : 23-31

Elsevier

Access to resources Recommend Favorite

Fatty Acid Amide Hydrolase: A Potential Target for Next Generation Therapeutics

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 759-772

Bentham Science Publishers

Access to resources Recommend Favorite

Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)

By Gifford A.N.   Bruneus M.   Lin S.   Goutopoulos A.   Makriyannis A.   Volkow N.D.   Gatley S.J.  

European Journal of Pharmacology, Vol. 383, Iss. 1, 1999-10 ,pp. : 9-14

Elsevier

Access to resources Recommend Favorite

Omega-3 fatty acid eicosapentaenoic acid. A new treatment for psychiatric and neurodegenerative diseases: a review of clinical investigations

By Song Cai   Zhao Shannon  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1627-1638

Informa Healthcare

Access to resources Recommend Favorite